BD Life Sciences-Biosciences organises roadshow on ‘Advances in Clinical Flow Cytometry’

Organised in Bengaluru, Dhaka, Lucknow and Mumbai, each of the ACFC events also enabled discussions by experts from the clinical fraternity on critical aspects of clinical diagnostics including: Standardisation, Performance, Accreditation, Automation and Collaboration

To enable knowledge-sharing of best practices and technological advancement on clinical applications of flow cytometry, BD Life Sciences-Biosciences, a segment of BD (Becton, Dickinson and Company) recently organised the ‘Advances in Clinical Flow Cytometry’ (ACFC) multi-city roadshow for clinicians and physicians. Organised in Bengaluru, Dhaka, Lucknow and Mumbai, each of the ACFC events also enabled discussions by experts from the clinical fraternity on critical aspects of clinical diagnostics including: Standardisation, Performance, Accreditation, Automation and Collaboration.

Commenting on the ACFC initiative, Pavan Mocherla, Managing Director, BD India/South Asia said, “Over the years, flow cytometry has proven to be an invaluable asset in several clinical applications and plays an important role in clinical diagnostics and research. Cognizant of this and aligned with our purpose of Advancing the World of Health, BD has been organizing the Advances in Clinical Flow Cytometry (ACFC) knowledge sharing sessions for clinicians and hematologists across the country since 2018.  Our objective is to provide a platform to discuss new processes, and leading technology best practices to enable better patient outcomes and I am happy to share that we engage with more than 150 leading clinicians and medical professionals annually under this platform.”

At this edition of ACFC, several clinical applications and importance of quality were discussed by speakers from the clinical fraternity. Key highlights of the discussions were:

• Case studies on leukemia and lymphoma as well as minimal residual disease amongst others.
• Deliberation on standard operating protocols, accuracy and standardisation of flow cytometry assays.
• Importance of quality and standardisation of assays in clinical flow cytometry.